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Abstract
The cholinergic system is a neuromodulatory neurotransmitter system involved in a variety of brain processes, including
learning and memory, attention, and motor processes, among others. The influence of nicotinic acetylcholine receptors of
the cholinergic system are moderated by lynx proteins, which are GPI-anchored membrane proteins forming tight
associations with nicotinic receptors. Previous studies indicate lynx1 inhibits nicotinic receptor function and limits neuronal
plasticity. We sought to investigate the mechanism of action of lynx1 on nicotinic receptor function, through the generation
of lynx mouse models, expressing a soluble version of lynx and comparing results to the full length overexpression. Using
rotarod as a test for motor learning, we found that expressing a secreted variant of lynx leads to motor learning
enhancements whereas overexpression of full-length lynx had no effect. Further, adult lynx1KO mice demonstrated
comparable motor learning enhancements as the soluble transgenic lines, whereas previously, aged lynx1KO mice showed
performance augmentation only with nicotine treatment. From this we conclude the motor learning is more sensitive to
loss of lynx function, and that the GPI anchor plays a role in the normal function of the lynx protein. In addition, our data
suggests that the lynx gene plays a modulatory role in the brain during aging, and that a soluble version of lynx has
potential as a tool for adjusting cholinergic-dependent plasticity and learning mechanisms in the brain.
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Introduction
The cholinergic system is a critical modulatory system
governing complex processes in the brain. Nicotinic receptors of
the cholinergic system bind to the endogenous neurotransmitter
acetylcholine, as well as the exogenous drug, nicotine. Activation
of such receptors can augment neurotransmitter release, synaptic
transmission and enhance synaptic plasticity [1]. Nicotinic
receptor activation can also influence some forms of learning
and memory, including fear conditioning [2,3], avoidance learning
[4], water maze [5,6], and motor learning [7,8]. Several
mechanisms exist to control the activity of the cholinergic system
[9,10,11,12,13]. Regulating the activity levels of the cholinergic
system, or achieving optimal cholinergic tone in the brain, can be
an effective means of controlling the extent of plasticity
mechanisms.
One mechanism of cholinergic regulation previously reported is
achieved through the modulator, lynx1 [14]. Our studies indicate
that lynx1 can form stable complexes with nicotinic receptors,
resulting in lower agonist affinity, faster desensitization and slower
recovery from desensitization of a4b2 nicotinic receptors, acting as
a molecular brake on nicotinic receptor function [15]. Removal of
this brake, such as in lynx1 null mutant (lynx1KO) can exhibit
features of enhanced cholinergic tone – greater agonist sensitivity
and intracellular calcium levels and reduced desensitization in
response to nicotine in the brain [9,16]. The resulting nicotinic
receptor hypersensitivity can lead to enhancements in synaptic
plasticity [17] and improved fear conditioning [16]. While aged
lynx1KO mice were not affected in rotarod performance, there
was a significant increase in lynx1KO mice in motor learning
when treated with nicotine. These data support the hypothesis that
lynx1KO mice are more sensitive to the effects of nicotine than
wild-type mice and that this enhanced cholinergic tone resulted in
improved learning on the rotarod task. Although lynx1 is widely
expressed throughout the brain, it shows particularly high levels in
select cells within the cerebellum. Therefore, we sought to
investigate further the mechanism of action of lynx1 on nicotinic
receptor function, extending some of the initial observations of
enhanced motor learning into the cerebellum by manipulating the
levels of the lynx1 gene.
The rotarod task measures motor coordination and can also
measure motor learning [18]. The cerebellum is highly implicated
in the functioning of this task, and it is a well documented site of
action for other learning paradigms [19] such as conditioned eye-
blink [20,21,22]. The main function of the cerebellar circuit is to
refine sensory and motor information – integrating these inputs to
fine tune motor activity to aid in motor coordination [23]. The
Purkinje cell is the main output neuron in the cerebellar cortex
and sends inhibitory signals to the deep nuclear neurons of the
cerebellum. The cerebellar Purkinje cell is a highly integrative cell,
which segregates its many afferent inputs into discrete subdomains.
Its main excitatory inputs are received by parallel fibers synapsing
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onto distal dendrites of Purkinje cells, and climbing fibers
synapsing onto the somatodendritic region near to Purkinje cell
bodies. The majority of inhibitory inputs onto Purkinje cells arise
from stellate and basket cells in the molecular layer [19], synapsing
onto Purkinje proximal dendrites and cell bodies, respectively.
Synaptic alterations during the pairing of presynaptic stimuli can
be induced by removing inhibition, indicating that alterations in
excitatory/inhibitory balance could influence synaptic plasticity in
this circuit. Therefore, the cerebellar cortex is a useful region to
probe the effect of cholinergic modulation of neuronal circuits.
The cholinergic system has been reported to mediate release of
neurotransmitter in the cerebellum [24,25,26,27,28], and there-
fore influence cerebellar activity [29,30] in normal [31] and
abnormal [32] brain function. Both muscarinic and nicotinic
receptors have been localized in the cerebellar cortex [33]. In the
rat cerebellum, a4 nicotinic receptor subunit immunoreactivity
has been identified in the cell bodies in the molecular, granule and
Purkinje cell layers and in pre-synaptic terminals to Purkinje cells
[34]. a7 nicotinic receptor subunit immunoreactivity can be found
in rat Purkinje cell and granule cell dendrites, but not in granule
cell somata [35]. Several different subtypes of nicotinic receptor
have been reported in the cerebellum, approximately half of which
are a4b2* receptors (composed of a4b2, a3a4b2, and a4b2b4),
and approximately half of which are a3b4* receptors (composed of
a3b4, a3b2b4 a3b2b4, and a3a4b4 [36]. Because of this
differential distribution, selective modulation of these subtypes
would likely have a complex effect on the function of the cerebellar
circuit. In the cerebellum, lynx1 message has been found at high
levels in deep nuclei, and at moderate levels in Purkinje cells.
Lynx1 protein in the cerebellar cortex is restricted to the
somatodendritic compartment of Purkinje cells, a neuronal
subdomain that is correlated with a defined set of afferent inputs,
climbing fiber excitatory input, and stellate/basket neuron
inhibitory input.
Lynx genes and family members consist of both secreted
[37,38,39,40,41,42], and membrane-bound variants
[9,43,44,45,46,47,48,49,50]. The majority of the mammalian
family members are membrane-bound peripheral membrane
proteins, anchored to the membrane through sugar-lipid interac-
tions via a glycosylphospholipid (GPI)–linked anchor. Previously
we reported that purified lynx1 protein has modulatory capability
over nicotinic receptors in vitro [14], distinct from effects of co-
expression of the full-length membrane anchored form of the
protein [15]. To further probe the biophysical mechanism of
action of the membrane anchor for lynx function, we employed
genetic engineering strategies to express membrane bound and
secreted lynx isoforms in the brains of mice utilizing three
genetically modified mouse lines.
Results
A secreted version of the lynx1 protein lacking the consensus
sequence for the GPI attachment (sec-lynx1, Figure 1A) was used
to construct an over-expression transgenic line. In the native lynx1
gene, a leading signal sequence directs the polypeptide across the
membrane, while the C-terminal hydrophobic consensus sequence
directs attachment of the nascent polypeptide to the GPI anchor.
During the process of biosynthesis of GPI-anchored proteins, the
C-terminal signal sequence directs the nascent polypeptide to the
membrane until the attachment of the anchor occurs. Upon
attachment of the GPI moiety, the embedded GPI consensus
sequence is cleaved from the mature polypeptide. By removing the
consensus sequence for the attachment of the GPI-moiety, the lynx
polypeptide variant would be directed across the plasma mem-
brane, but not anchored there.
Figure 1. Summary of three transgenic lynx1 constructs: L7 lynx1, L7 secreted lynx1, and lynx1 BAC. (A) L7-lynx1 construct, upper,
utilizing a pcp (L7) promoter sequence in front of a full length lynx1 cDNA contained the full length lynx1 coding sequence. Lower, L7-sec-lynx1, pcp
(L7) promoter driving expression of a secreted variant of lynx1, lacking the final asparagine residue that makes up the mature form of lynx1, and
lacking the GPI-anchor hydrophobic consensus sequence. An in-frame HA sequence replaces the GPI anchor sequence. (B) Representative structural
model of lynx1 (right hand molecule) with associated GPI-linked tether (red circles) to the plasma membrane (grey). Model is based on the NMR
structure of lynx1 [56]. Left hand molecule, the secreted variant of lynx1 can translocate freely across the plasma membrane and diffuse into the
extracellular and/or synaptic space. (C) BAC modification strategy for the generation of a lynx1 modified BAC transgenic mouse line.
doi:10.1371/journal.pone.0043302.g001
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To assess the consequence of an alternate isoform to the
functioning of neuronal circuits, we used the cerebellar Purkinje
cell specific promoter, L7, to drive expression of this secreted lynx
variant (L7-sec-lynx1) (Figure 1A, lower). We then employed a
learning assay that is dependent on the action of the Purkinje cell,
the accelerating rotarod paradigm, a test of motor coordination
and learning. Two independent founder lines were bred to
C57BL/6 mice, and the progeny were tested for motor
coordination and learning. Founder line one of the L7-sec-lynx1
transgenic mouse line demonstrated no basal differences in motor
performance in an initial trial as compared to wild-type littermate
control mice. Upon subsequent training trials, however, L7-sec-
lynx1 mice showed a significant improvement by the fifth trial on
the first day of training (Figure 2A). On subsequent training days,
the mutant mice maintained the improved rotarod ability across
five days of training (Figure 2B). To determine whether motor
alterations are due to learning enhancements vs. differences in
motor function or coordination, two different learning parameters
were used, a slow and a fast acceleration speed (Figure 2C). In
both conditions, progeny from two independent transgenic
founder lines of the same transgene demonstrated a learning
enhancement after training (Figure 2D–E). Because improvements
in rotarod performance were not observed until latter trials, these
data are indicative of improved motor learning, as opposed to
motor coordination or performance. Motor learning enhance-
ments were observed in a second independent founder line for the
L7-sec-lynx1 transgene, supporting a specific effect of the soluble
lynx polypeptides, as opposed to differential integration sites of the
lynx transgenic lines (Figure 1D).
A second transgenic construct was generated utilizing the same
L7 promoter to over-express the full-length version of the lynx1
polypeptide, L7-lynx1 transgenic mice (Figure 1A, upper). When
expressed in transgenic mice, the full-length normal variant of
lynx1 would attach at the plasma membrane through its GPI
anchor, only in cerebellar Purkinje neurons. As with the L7-sec-
lynx1 transgenic mice, the L7-lynx1 transgenic mice demonstrated
no basal differences in motor performance, on the first trial. In
contrast, however, motor performance in the L7-lynx1 transgenic
mice never demonstrated significant differences in motor learning
or performance across any of the training days (Figure 3A and B).
These data indicate that lynx1 protein levels in Purkinje cells of
wild-type are not limiting, as increasing lynx1 in this cell type has
no effect on this behavior.
In a third independent transgene, we employed a bacterial
artificial chromosome (BAC) recombineering strategy using the
lynx1 genomic locus to over-express full-length lynx1 under
control of the lynx1 promoter. When expressed in the BAC
transgenic mice, lynx1BAC transgenic mice, full-length membrane
bound lynx1 would be expressed in all lynx expressing cells of
mice. These lynx1BAC transgenic mice were tested in the same
rotarod paradigm, and showed no differences compared to wild-
type mice on the initial test day, indicating no significant
differences in motor performance (Figure 3C). On subsequent
training days, lynx1–BAC transgenic mice displayed similar
abilities as compared to their wild-type counterparts, indicating
lynx1 BAC mice were not improved in motor learning (Figure 3D).
Results from these two overexpression transgenic lines indicate
that levels of the lynx1 protein are not limiting for the full
expression of the behavioral phenotype.
We previously observed that motor learning was enhanced
when aged lynx1KO mice were treated with a chronic course of
nicotine (Miwa et al., 2006). In comparing naı¨ve adult mice (8–
12 weeks of age) with aged mice (.9 months), we found a greater
enhancement of motor learning in young adult mice, as compared
to aged lynx1KO mice (Figure 3E). These data indicate that
manipulations to inhibit lynx dosage may be more advantageous
than addition of lynx levels, and that there is an age related effect
of lynx1. Alterations in anxiety cannot account for the perfor-
mance differences in lynx1KO mice, as they were normal in light-
dark box (data not shown), open field, or elevated-plus maze assays
[16]. These data, taken together indicate ectopic expression or
expression of lynx variants leads to increases in motor learning.
Discussion
In this study we probed the ability of a lynx polypeptide to
modulate neuronal circuits using conventional and BAC transgen-
esis. Previous studies show that lynx helps to regulate the level of
cholinergic activity through direct interactions with nicotinic
receptors. The present data demonstrate that a non-membrane
bound form of the lynx1 polypeptide, secreted lynx1, has distinct,
positive neuromodulatory effects on motor learning. The motor
enhancement due to expression of secreted lynx1 occurs in the
context of wild-type levels of the normal protein. Over-expression
of full length lynx1 did not produce differences in motor learning
as compared to wild-type mice, indicating that lynx levels do not
limit the expression of this behavior. Furthermore, differential
effects of full length vs. secreted lynx1 overexpression in cerebellar
Purkinje cells suggest that the GPI-anchor is a critical component
of normal lynx1 function. Finally, because lynx1KO mice display
similar motor learning enhancements as the sec-lynx1 Tg lines,
this supports the idea that the secreted version of lynx1 act
differently from the full length, membrane-bound version. We
hypothesize that secreted lynx1 can act as a dominant negative
and compete off wild-type membrane-bound lynx1, creating an
effect similar to the lynx1KO mice. Alternatively, the secreted
version could reach new sites in the cerebellum not normally
reached by the lynx1 protein. Taken together, these data suggest
that delivery of a lynx polypeptide could therapeutically regulate
cholinergic activity to achieve enhancements in synaptic plasticity,
learning and/or memory.
Because overexpression of lynx had no effect on either L7-lynx1
or lynx1BAC transgenic mice, we can conclude that lynx1 levels
are not limiting in Purkinje cells with respect to rotarod learning
ability. Rather, we have seen that the brain is more sensitive to loss
of lynx function rather than overexpression. Improved rotarod
performance can also be elicited in adult lynx1KO, a sign of
enhanced motor learning ability. We can partially rule out other
factors, such as anxiety, that could contribute at a motivational
level to the performance of these mice. We cannot completely
exclude the possibility that fatigue could differentially influence
motor performance between the two genotypes; the improved
ability in the L7-sec-lynx mice –expressed only in Purkinje cells-
indicates that the site of change is within the cerebellum,
decreasing the likelihood that muscle fatigue is a factor in our
results. Furthermore, we have not discerned a notable drop-off in
performance from the first training trial to the last of each day,
potentially an indicator of muscle fatigue, between the different
genotypes. Lastly, adult lynx1KO mice demonstrated motor
learning enhancements, as compared to aged lynx1KO mice,
which showed performance augmentation only with nicotine
treatment [16]. Given the significant degeneration in lynx1KO
over one year of age, it is likely that motor loss of function
accompanies the degeneration in aged lynx1KO.
The cerebellum has been implicated in some forms of plasticity
and learning. Purkinje cell firing is controlled through a balance of
excitatory vs. inhibitory inputs [19]. Synaptic alterations during
the pairing of presynaptic stimuli can be induced by removing
Learning Enhancements and Lynx1
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inhibition, indicating that modulating inhibition could influence
synaptic plasticity in this circuit. We have considered two potential
models of action of secreted lynx in the L7-sec-lynx1 transgenic
mice (Figure 4), which can be broadly categorized as a cell
autonomous model (Figure 4B), and a circuit based model
(Figure 4C).
Cell autonomous, dominant negative model: In normal cases,
lynx1 is bound to the cell surface of Purkinje cells, and is not
expressed in presynaptic neurons (Figure 4A). In the cell
autonomous model (Figure 4B), the secreted lynx1 could
outcompete the binding of the GPI-tethered lynx1 to the nicotinic
receptor in the Purkinje cell, creating a dominant negative effect
and leading to nicotinic receptor hypersensitivity. The similarity in
learning enhancements between the secreted Tg and the lynx1KO
support this model. This competition could occur on the cell
surface, or during the trafficking of the receptor. In previously
published reports, however, secreted lynx amplified ACh evoked
current in a4b2 nicotinic receptor-injected oocytes, when no lynx
was present, indicating that at least part of the function of lynx has
the potential to function through direct action on receptor gating,
Figure 2. Rotarod performance for L7-sec-lynx1 transgenic mice. (A) Line 1. No differences in performance were observed initially, but the
transgenic mice (L7-sec-lynx1 Tg) outperformed their wild-type littermates beginning at the 5th trial. These data indicate that there are no motor
performance differences in the transgenic mice vs. wildtype mice, but that there is a significant improvement in motor learning behavior. Y axis is in
seconds; X axis is trial number. P,0.05. (B) Line 1. Motor performance over five consecutive training days. Average of all trials per day indicates a
significant performance enhancement in L7-sec-lynx1 Tg as compared to their wild-type littermate controls. Y axis is in seconds, X axis is in days. (C)
Line 2. Motor performance using a slow acceleration rotarod paradigm (0.1 RPM/sec). Significant enhancements in rotarod performance in L7-sec-
lynx1 Tg mice were observed in latter trials. Y axis is in seconds; X axis is in trials. P,0.05. (D) Table of data collected for two independent founder
lines of the L7-sec-lynx1 transgene tested on an accelerating rotarod paradigm, with two separate acceleration paradigms of the rotarod test (modes)
used, slower (0.1 RPM/sec.) and faster (1 RPM/sec.) accelerating paradigm. In both paradigms, both L7-lynx1 transgenic mouse lines demonstrated a
significant enhancement in motor learning but no differences in baseline motor performance. (E) Summary of the effects of motor learning on the
two lines of the same L7-sec-lynx1 transgenic mice. The maximal daily performance from all training days is plotted as a percentage relative to wild-
type. ‘‘f’’ and ‘‘s’’ suffixes refer to the faster or slower acceleration, respectively.
doi:10.1371/journal.pone.0043302.g002
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and not only through a dominant negative competition of
endogenous lynx1.
Circuit based alteration, ectopic expression model (Figure 4C):
Because the secreted variant of lynx1 is not anchored to the
plasma membrane, it has the potential to be released into the
Figure 3. Comparison of motor learning effects across several genetically modified lynx lines. Overexpression lines, L7-lynx1 and
lynx1BAC mice, which over-expressed full length lynx1 in Purkinje cells, and lynx1-expressing cells, respectively, did not display significant differences
in motor learning. (A) L7-lynx1 transgenic mice, overexpressing full length lynx1 in Purkinje cells, showed no differences in motor performance or
learning as compared to their wild-type counterparts. Y axis is in seconds, X is in trials. (B) L7-lynx1 transgenic mice exhibited no learning
improvements over that of wild-type littermates. Y axis is in seconds, X axis is in days. (C) lynx1 BAC transgenic mice showed no difference in motor
performance as compared to wild-type littermates in initial training trials on the rotarod. Y axis is in seconds, X is in trials. No significant differences
were observed. (D) On subsequent training days, lynx1BAC mice did not show a difference in motor learning. Y axis is in seconds. No significant
differences were observed. (E) Comparisons of motor learning across lines. Data is represented for each line as a percentage over the performance of
their wild-type counterparts. The improvement in motor learning of L7-sec-lynx1 transgenic mice contrast with expression of full-length lynx1 using
lynx1BAC transgenesis. Rotarod motor learning was also sensitive to removal of lynx (lynx1 KO), and demonstrated a significant increase over wild-
type controls. Aged mice, (.1 yr), showed no motor enhancements unless treated with nicotine [16]. Y axis is percentage over wild-type controls.
Data depicted represent the seventh training trial for each group.
doi:10.1371/journal.pone.0043302.g003
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synaptic or extracellular spaces and reach sites otherwise not
available to the native, GPI-bound version of wild-type lynx1. We
have detected lynx1 binding sites in the cerebellum that do not
correspond to lynx expression. Purified lynx1-fc binds to sites in
the cerebellar molecular layer (i.e. inhibitory stellate and basket
neurons), while lynx1 gene expression is confined to Purkinje cells
in the cerebellar cortex. The untethered lynx1 variant in the L7-
sec-lynx1 transgenic line could reach stellate/basket neurons
ectopically. We would expect this to influence neurotransmitter
release from terminals of stellate/basket neurons, due to the
modulatory properties of lynx. Reducing nicotinic receptor
function on stellate and basket cell interneurons could result in a
disinhibition of Purkinje cells. It has been suggested that synaptic
inhibition onto Purkinje cells can fine-tune cerebellar circuit
activity [51], mediate synaptic plasticity [52] and enhance motor
learning functions [53]. Alterations in the firing patterns of
Purkinje cells will have consequences to motor coordination and
learning. Purkinje cells are the major output of the cerebellar
cortex, and loss of Purkinje cells activity through dysfunction can
lead to a reduction of motor coordination and learning [54].
Manipulation of the lynx gene has the potential to alter the
excitatory/inhibitory balance within the cerebellar cortex. There-
fore, reduced inhibitory output onto Purkinje cells, could create a
permissive environment for synaptic alterations underlying motor
learning events.
The experiments conducted here demonstrate that membrane
tethering is important for the proper function of lynx1. GPI-
anchored proteins have an affinity for a specialized lipid domain
referred to as lipid rafts, and as such undergo differences in sorting
than transmembrane proteins [49]. It has been proposed that GPI-
anchored proteins are capable of directing receptors they bind to
into rafts, which can influence sorting, nucleation sites of receptor
complexes, and more [55]. Because of the possibility of specific
sorting the GPI anchor can confer, the secreted lynx variant in the
L7-sec-lynx1 transgenic mouse line could fail to elicit the normal
function of membrane-bound lynx1 due to incorrect localization
and/or number of receptors. In vitro studies on the action of lynx1
on a4b2 nicotinic receptors indicate that application of purified
soluble form of lynx has different effects in oocytes as compared to
full-length lynx1 when co-expressed with a4b2 nicotinic receptors
[14,15], but whether these differences could be due to receptor
sorting differences remains to be determined.
Figure 4. Two schemes for possible modes of action of secreted lynx on nicotinic receptors within synapses. (A) Schematic diagram of
a synapse in WT mice. Schematic model of nicotinic receptors and lynx1 interaction at a Purkinje cell synapse. Models are based on the crystal
structure of AChBP [57] and the NMR structure of lynx1 [56]. Lynx1 is depicted as binding at the subunit interface of the pentameric channel, based
on a-bungarotoxin binding. Lynx1 expression is expressed in the post-synaptic cell (Purkinje cell), and is not expressed in the presynaptic neuron
(stellate/basket neuron). Tethered to the membrane by it GPI-anchor, lynx is depicted as having access to a nicotinic receptor binding site at the post-
synaptic face only. (B) Schematic model 1 of sec-lynx1 function – cell autonomous, dominant negative model. Schematic representation of Purkinje
cell synapses in L7-sec-lynx1 Tg mice. Binding of secreted lynx1 to the same subunit interface of the nicotinic receptor could compete off the binding
of native full-length GPI-anchored lynx1, and thereby exert a dominant negative effect. This model implies that the secreted version of lynx1 has
either no effect or a differential function as compared to the membrane bound version of lynx1, but maintains nicotinic receptor binding capability.
(C) Schematic model 2 of sec-lynx1 function – circuit based, ectopic expression model. In this model, the soluble lynx1 secreted from the post-
synaptic Purkinje cells diffuses extracellularly, accessing nicotinic receptors located on terminals of pre-synaptic neurons (stellate/basket cell). In this
model, the ectopic expression of lynx1 in pre-synaptic sites can lead to suppression of activity or neurotransmitter release, leading to dis-inhibition
onto Purkinje cells. This dis-inhibition can lead to alterations in excitatory/inhibitory balance and motor learning.
doi:10.1371/journal.pone.0043302.g004
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In this particular study, we employed the rotarod assay test of
motor performance and learning, but our analysis with the lynx1
knock-out mouse line suggests that lynx1 is important in other
learning and memory functions [16] and plasticity mechanisms as
well [17]. Therefore, a therapeutic lynx polypeptide may be useful
in treating memory dysfunctions across multiple modalities.
Methods
Transgenic constructs
L7-sec-lynx1 transgenic construct. A non-membrane
bound version of lynx1 was subcloned behind the pcp2 (L7)
promoter to drive specific expression of a secreted form of lynx1
specifically in Purkinje cells. A Not1-Apa1 fragment from a lynx1
cDNA construct, CMV2611, was subcloned into the pCEVII
expression vector. The template from which the Not1-Apa1
fragment was digested, CMV2611, was constructed through PCR
amplification of a 4.5 kb lynx1-containing cDNA, GC26.2 with
Not1 and Apa1 restriction sites designed in the 59 and 39 primers,
respectively. The 39 primer produced an in-frame HA tag and stop
codon after the last cysteine residue that makes up the ly-6
consensus motif, deleting the final asparagine residue before the
consensus sequence for the attachment of the GPI-anchor. DNA
was linearized with Apa1, and the fragments were purified by
cesium chloride centrifugation and phenol chloroform extraction.
The construct was introduced into CBA/C57BL/6 hybrid mice by
DNA injection into embryos using standard transgenic techniques.
L7- lynx1 transgenic construct. Overexpression of lynx1 in
Purkinje cells was generated by subcloning a lynx cDNA fragment
from a full-length lynx1 construct, CMV-269. A Not1-Apa CMV-
269 fragment was subcloned into pCEVII and purified as above.
The CMV-269 construct was generated using the same 59 primer
as for CMV-2611, and a 39 primer pair at a similar position on the
lynx1 gene, near or at the start of the 39UTR.
Lynx1BAC transgenic construct. A lynx1 open reading
frame probe was used to screen a mouse BAC library for a BAC
clone containing the lynx1 gene. (BAC clone 77K17). The PCR
primer pair used to generate CMV269, was used to amplify a
genomic fragment of the lynx BAC clone 77K17 to create a 59
homology arm (A box) flanked by XhoI sites, and subcloned with
Xho1 into an IRES-GFP building vector (pBV1). The B box was
created by subcloning a Xba1 fragment from lynx1 cDNA M25 in
exon IV into the pBV1. The entire building vector insert was
cloned as a Sal1 fragment into the recA shuttle vector (pSV1recA).
The pSV1recA vector containing the lynx1 homology arms was
transformed into 77K17 BAC-containing bacterial cells and plated
on tetracycline and chloramphenicol plates at 30uC to select for
co-integration of the psV1recA vector. To ensure complete
homologous recombination, plates were incubated at 43uC to
remove the recombination capacity of the cells, and to thus
remove incompletely integrated shuttle vectors. Correct cointegra-
tion was verified by Southern blot analysis. Co-integrates were
then plated on chloramphenicol plates at 43uC to induce
resolution, and chloramphenicol and fusaric acid at 37uC to select
for loss of the tet gene. Resolved BACs were screened by Southern
blot using radiolabeled probes of each of the lynx1 open reading
frame, A box sequence, and B box sequences. DNA preparation
was conducted in the same manner as the L7-sec-lynx1 construct.
Mouse Breeding
Progeny of the positive transgenic founder mice were bred with
BL/6 mice to produce F1 positive and wild-type littermates, and
maintained under a standard 12 hour light-dark cycle. Positive F1
transgenic mice and their wild-type littermates were tested on
rotarod at 7–12 weeks of age. Testing was conducted on age and
sex matched littermate controls. A fourth transgenic mouse line
was generated, a secreted form of lynx driven by the lynx1
genomic regions contained on BAC 77K17, but the founder mice
did not transmit the transgenic allele to their progeny and were not
tested (data not shown). Lynx1KO mice were tested at 8–12 weeks
of age (adult mice), and aged mice were tested over 12 months of
age. Rockefeller IACUC committee reviewed the procedures used
in these experiments and approved this study. The animals were
handled according to Animal Welfare guidelines, and were not
subjected to any procedures that were painful or induced suffering.
Rotarod motor learning paradigm
Genetically modified animals were tested for performance in an
accelerating rotarod test. In the rotarod assay, mice are placed on
a rotating rod at the slowest speed, at 0.1 RPM, and accelerated at
a constant rate of acceleration, either 1.0 RPM/sec. rate of
acceleration (fast acceleration) or 0.1 RPM/sec. (slow accelera-
tion). The latency of each trial was measured as the time the
mouse stayed on the rod until it either fell off of the rotating rod, or
clung to the rod without running for an entire revolution. Eight
trials per day were tested for five days. Initial trials of testing
evaluate motor coordination in the mice, whereas subsequent
training trials measure the adaptability of the circuit, and thus test
motor learning or plasticity. Similar results were obtained with
four trials per day on the first training day.
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